What to Do When a Biotech Stock Skyrockets
For a host of reasons, it's not uncommon to see a biotechnology company's share price double virtually overnight. A report about the favorable performance of a cutting-edge technology, a green light from regulators, or positive signs from a clinical trial can -- and do -- light outsized fires under such stocks.
And an unfortunate fact of life (for me, at least) is that when biotech stocks head to the moon, it's hard not to be jealous of people who invested in them before liftoff.
It's wisest to keep that jealousy at bay, though. If there's one thing I've learned about investing in this industry, it's that trying to jump on board a biotech stock when it's already shooting skyward can be a costly mistake.
Source Fool.com
